BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/20/2024 9:15:32 AM | Browse: 364 | Download: 1427
 |
Received |
|
2024-01-01 23:56 |
|
Peer-Review Started |
|
2024-01-01 23:56 |
|
First Decision by Editorial Office Director |
|
2024-02-24 07:11 |
|
Return for Revision |
|
2024-02-24 07:11 |
|
Revised |
|
2024-03-07 15:41 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-04-23 02:45 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-04-23 06:45 |
|
Articles in Press |
|
2024-04-23 06:45 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-05-10 09:19 |
|
Publish the Manuscript Online |
|
2024-05-20 09:15 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Prospective Study |
| Article Title |
Non-pancreatic hyperlipasemia: A puzzling clinical entity
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Krisztina Eszter Feher, David Tornai, Zsuzsanna Vitalis, Laszlo Davida, Nora Sipeki and Maria Papp |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the Economic Development and Innovation Operative Program Grant |
GINOP 2.3.2- 15-2016-00048 “StayAlive” |
| Human Resources Development Operational Program Grant of the National Research Development and Innovation Office |
EFOP-3.6.2-16-2017-00006 |
|
| Corresponding Author |
Maria Papp, DSc, FEBG, MD, PhD, Professor, Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Nagyerdei Blv 98, Debrecen H-4032, Hajdu-Bihar, Hungary. papp.maria@med.unideb.hu |
| Key Words |
Non-pancreatic hyperlipasemia; Acute pancreatitis; Glycoprotein 2; Acute kidney injury; Sepsis; Mortality |
| Core Tip |
Non-pancreatic hyperlipasemia is a common and puzzling clinical entity in the differential diagnosis of acute pancreatitis (AP). The etiology of NPHL varies; however, sepsis and acute kidney injury (AKI) are the most prevalent causes. NPHL was associated with a high in-hospital mortality rate (22.4%). A readily available laboratory marker, the neutrophil-to-lymphocyte ratio, with a cut-off value > 10.37, has been the best independent laboratory predictor of mortality, with a nearly 4-fold increased risk. In the laboratory diagnosis of AP, the presence of complications, especially sepsis and AKI, warrants clinical attention, as it has a significant negative impact on the diagnostic accuracy of lipase. |
| Publish Date |
2024-05-20 09:15 |
| Citation |
Feher KE, Tornai D, Vitalis Z, Davida L, Sipeki N, Papp M. Non-pancreatic hyperlipasemia: A puzzling clinical entity. World J Gastroenterol 2024; 30(19): 2538-2552
|
| URL |
https://www.wjgnet.com/1007-9327/full/v30/i19/2538.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v30.i19.2538 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
